Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain
Phase II Study of Hypofractionated Highly Conformal Radiotherapy With Helical Tomotherapy in Patients With Extracranial Oligometastases
Basic Trial Information
|Phase II||Treatment||Completed||Over 18||NCI||NCI-07-C-0230|
Special Category: NIH Clinical Center trial, NCI Web site featured trial
Eligibility criteria include the following:
- At least 18 years old
- Measurable disease
- More than 2 weeks since chemotherapy
- For more information about the eligibility criteria for this trial, refer to the Health Professional version.
Final eligibility for a clinical trial is determined by the health professionals conducting the trial.
Patients will undergo conformal radiation therapy every other day for 5 days (three treatments). They will also undergo an imaging procedure before and after each treatment.
Patients will fill out a pain questionnaire at the beginning of the study and at 1 and 3 months after finishing treatment.
After finishing treatment, patients will be evaluated at 1 and 3 months and every 3 months for up to 1 year.
For more details about this trial, refer to the Health Professional version of the trial summary.
If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.
Trial Contact Information
Trial Lead Organizations
NCI - Center for Cancer Research
|Official Title||A Phase II Study of Hypofractionated Highly Conformal Radiation with Helical Tomotherapy for Extra-Cranial Oligo|
|Trial Start Date||2007-10-02|
|Trial Completion Date||2010-05-06|
|Registered in ClinicalTrials.gov||NCT00550654|
|Date Submitted to PDQ||2007-10-02|
|Information Last Verified||2009-06-07|